TrialPloS one2017
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
Stuart McPherson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled ittrialcites it